Aster Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$852K Buy
+4,373
New +$906K 0.18% 170
2026
Q1
Sell
-802
Closed -$193K 1254
2025
Q4
$193K Sell
802
-1,450
-64% -$371K 0.08% 229
2025
Q3
$616K Buy
+2,252
New +$615K 0.31% 74
2025
Q2
Sell
-744
Closed -$174K 1492
2025
Q1
$174K Buy
+744
New +$174K 0.03% 516

Other funds holding RMD

Aster Capital Management's RMD Position: Q2 2026 in Review

Aster Capital Management opened a new position in ResMed (RMD) in Q2 2026: 4,373 shares worth $852K. The stake represents 0.18% of the portfolio and ranks #170 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in RMD as recently as Q4 2025.

Aster Capital Management first reported a position in RMD in Q1 2025 and has held it in 4 quarters since. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Aster Capital Management held 4,373 shares of ResMed worth $852K as of Q2 2026.
  • ResMed was a new Aster Capital Management position in Q2 2026.
  • ResMed made up 0.18% of Aster Capital Management's portfolio in Q2 2026, its #170 holding.
  • Aster Capital Management first reported a position in ResMed in Q1 2025 and has held it in 4 quarters since.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.